arBtrage CAPITALIZING MARKETS checking… Sign in

ArriVent BioPharma, Inc.

AVBP Health Care Biotechnology: Pharmaceutical Preparations
$30.35
▼ -8.3% Today
as of Jun 7, 07:09 ET
Last 30 days +1.03% Apr 28 → Jun 05
$25.59 $27.61 $29.62 $31.63 $33.65 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$32.80
High
$32.98
Low
$30.30
Volume
$626,021
Avg Vol
$419,911
Mkt Cap
$1.3B
P/E (TTM)
Beta
52w High
$33.09
52w Low
$16.10
Div Yield
Shares Out
$45M

Overview

52-week range
$16
$33
84% of range
Avg surprise (last 2)
-98.5%
Avg reaction (last 2)
-1.2%
0% positive
Latest IV / EM
114%
EM ±15.7% · $30 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-10.79$-8.24$-5.70$-3.15$-0.61 Actual $-10.79Actual $-5.52Actual $-0.70Actual $-0.65Actual $-0.61Actual $-1.90Est $-0.66Actual $-0.90Actual $-0.83Actual $-0.96Est $-0.88 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-64M$-54M$-43M$-32M$-22M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.96 $-0.88 -9.1% +49.5% -1.6% earnings
Tue Sep 30, 2025Sep 2025 $-0.83 financials
Mon Jun 30, 2025Jun 2025 $-0.90 financials
Mon May 12, 2025Mar/2025 $-1.90 $-0.66 -187.9% -0.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.61 financials
Sun Jun 30, 2024Jun 2024 $-0.65 financials
Sun Mar 31, 2024Mar 2024 $-0.70 financials
Sat Sep 30, 2023Sep 2023 $-5.52 financials
Fri Jun 30, 2023Jun 2023 $-10.79 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-46M$-38M$-34M$-67M$-24M$-26M
Net income$-43M$-35M$-31M$-64M$-21M$-22M
EPS (diluted)$-0.96$-0.83$-0.90$-1.90$-0.61$-0.65

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$62M$46M$113M$113M$50M$74M$283M$299M
Inventory
Total current assets$349M$333M$321M$250M$186M$227M$292M$309M
Total assets$349M$333M$327M$270M$215M$275M$293M$309M
Long-term debt
Total liabilities$25M$26M$22M$20M$13M$17M$15M$12M
Total equity$324M$307M$305M$250M$203M$258M$277M$297M

Implied volatility — last 90 days

108%111%113%116%118% Jun 07 — IV 114% · EM ±15.7%

Sector peers